Here, we investigated whether long-term increased plasma levels of glucagon contribute to the pathophysiological changes seen in diabetic nephropathy, using mouse models of long-term activation and inactivation of glucagon receptor signaling. The gene discussed is GCG; the disease is diabetic kidney disease.